17856-1927 NDC - METHADONE HYDROCLORIDE ()

Drug Information

  • Product NDC: 17856-1927
  • Proprietary Name: Methadone Hydrocloride
  • Non Proprietary Name:
  • Active Ingredient(s): 10 mg/mL METHADONE HYDROCHLORIDE
  • Administration Route(s):
  • Dosage Form(s):
  • Pharmacy Class(es): Full Opioid Agonists [MoA]; Opioid Agonist [EPC]

Labeler Information

Field Name Field Value
Labeler Name: ATLANTIC BIOLOGICALS CORP.
Product Type:
FDA Application Number: ANDA212093
Marketing Category: ANDA
Start Marketing Date:11/2/2020
End Marketing Date:7/15/2022
DEA Schedule:CII

Package Information

No. Package Code Package Description Billing Unit
117856-1927-160 SYRINGE in 1 BOX, UNIT-DOSE (17856-1927-1) / 1 mL in 1 SYRINGE
217856-1927-272 CUP, UNIT-DOSE in 1 BOX, UNIT-DOSE (17856-1927-2) / 5 mL in 1 CUP, UNIT-DOSE
317856-1927-360 SYRINGE in 1 BOX, UNIT-DOSE (17856-1927-3) / .5 mL in 1 SYRINGE
417856-1927-4120 SYRINGE in 1 BOX, UNIT-DOSE (17856-1927-4) / .5 mL in 1 SYRINGE
517856-1927-572 CUP, UNIT-DOSE in 1 BOX, UNIT-DOSE (17856-1927-5) / 2.5 mL in 1 CUP, UNIT-DOSE
617856-1927-660 SYRINGE in 1 BOX (17856-1927-6) / .25 mL in 1 SYRINGE
717856-1927-71 SYRINGE in 1 BAG (17856-1927-7) / .5 mL in 1 SYRINGE
817856-1927-81 SYRINGE in 1 BAG (17856-1927-8) / 1 mL in 1 SYRINGE
917856-1927-91 SYRINGE in 1 BAG (17856-1927-9) / 2.5 mL in 1 SYRINGE

NDC Record

Field Name Field Value Definition
PRODUCT NDC17856-1927The labeler code and product code segments of the National Drug Code number, separated by a hyphen. Asterisks are no longer used or included within the product code segment to indicate certain configurations of the NDC.
PROPRIETARY NAMEMethadone HydroclorideThe proprietary name also known as the trade name is the name of the product chosen by the medication labeler for marketing purposes.
PROPRIETARY NAME SUFFIXdye-free, sugar-free, unflavoredA suffix to the proprietary name, a value here should be appended to the ProprietaryName field to obtain the complete name of the product. This suffix is often used to distinguish characteristics of a product such as extended release (“XR”) or sleep aid (“PM”). Although many companies follow certain naming conventions for suffices, there is no recognized standard.
START MARKETING DATE11/2/2020This is the date that the labeler indicates was the start of its marketing of the drug product.
MARKETING CATEGORY NAMEANDAProduct types are broken down into several potential Marketing Categories, such as NDA/ANDA/BLA, OTC Monograph, or Unapproved Drug. One and only one Marketing Category may be chosen for a product, not all marketing categories are available to all product types. Currently, only final marketed product categories are included. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.
APPLICATION NUMBERANDA212093This corresponds to the NDA, ANDA, or BLA number reported by the labeler for products which have the corresponding Marketing Category designated. If the designated Marketing Category is OTC Monograph Final or OTC Monograph Not Final, then the Application number will be the CFR citation corresponding to the appropriate Monograph (e.g. “part 341”). For unapproved drugs, this field will be null.
LABELER NAMEATLANTIC BIOLOGICALS CORP.Name of Company corresponding to the labeler code segment of the Product NDC.
PRODUCT NDC17856-1927The labeler code and product code segments of the National Drug Code number, separated by a hyphen. Asterisks are no longer used or included within the product code segment to indicate certain configurations of the NDC.
PROPRIETARY NAMEMethadone HydroclorideThe proprietary name also known as the trade name is the name of the product chosen by the medication labeler for marketing purposes.
PROPRIETARY NAME SUFFIXdye-free, sugar-free, unflavoredA suffix to the proprietary name, a value here should be appended to the ProprietaryName field to obtain the complete name of the product. This suffix is often used to distinguish characteristics of a product such as extended release (“XR”) or sleep aid (“PM”). Although many companies follow certain naming conventions for suffices, there is no recognized standard.
START MARKETING DATE11/2/2020This is the date that the labeler indicates was the start of its marketing of the drug product.
MARKETING CATEGORY NAMEANDAProduct types are broken down into several potential Marketing Categories, such as NDA/ANDA/BLA, OTC Monograph, or Unapproved Drug. One and only one Marketing Category may be chosen for a product, not all marketing categories are available to all product types. Currently, only final marketed product categories are included. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.
APPLICATION NUMBERANDA212093This corresponds to the NDA, ANDA, or BLA number reported by the labeler for products which have the corresponding Marketing Category designated. If the designated Marketing Category is OTC Monograph Final or OTC Monograph Not Final, then the Application number will be the CFR citation corresponding to the appropriate Monograph (e.g. “part 341”). For unapproved drugs, this field will be null.
LABELER NAMEAtlantic Biologicals Corp.Name of Company corresponding to the labeler code segment of the Product NDC.

Download Record

Download this NDC record record in Text format: Export

Download this NDC record record in Excel (CSV) format: Export

Download this NDC record record in XML format: Export

This page was last updated on: 12/6/2025

Previous Code
Next Code